These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32802815)

  • 1. Oncologic effects of adjuvant chemotherapy in patients with ypT0-2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis.
    Ha GW; Lee MR
    Ann Surg Treat Res; 2020 Aug; 99(2):97-109. PubMed ID: 32802815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adjuvant chemotherapy in rectal cancer patients with ypT0-2N0 after neoadjuvant chemoradiotherapy.
    Yang J; Deng Q; Chen Z; Chen Y; Fu Z
    Front Oncol; 2024; 14():1338098. PubMed ID: 38406812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
    Liao YT; Lin YL; Huang J; Hung JS; Lin BR
    Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
    Lu Z; Cheng P; Zhang MG; Wang XS; Zheng ZX
    Gastroenterol Rep (Oxf); 2018 Nov; 6(4):277-283. PubMed ID: 30430016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis.
    Kuo YH; Lin YT; Ho CH; Chou CL; Cheng LC; Tsai CJ; Hong WJ; Chen YC; Yang CC
    Front Oncol; 2022; 12():1087778. PubMed ID: 36591443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy.
    Zhang H; Huang Y; Sun G; Zheng K; Lou Z; Gao XH; Hao LQ; Liu LJ; Meng RG; Zhang W
    Ann Transl Med; 2020 Jun; 8(12):743. PubMed ID: 32647668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.
    You KY; Huang R; Zhang LN; Ding PR; Xiao WW; Qiu B; Chang H; Zeng ZF; Pan ZZ; Gao YH
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):719-28. PubMed ID: 25296560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
    Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis.
    Feng S; Yan P; Zhang Q; Li Z; Li C; Geng Y; Wang L; Zhao X; Yang Z; Cai H; Wang X
    Int J Colorectal Dis; 2020 Aug; 35(8):1355-1369. PubMed ID: 32488419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer.
    Petrelli F; Coinu A; Lonati V; Barni S
    Int J Colorectal Dis; 2015 Apr; 30(4):447-57. PubMed ID: 25433820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for patients with ypT0-2N0-category after neoadjuvant chemoradiotherapy for rectal cancer.
    Wan JF; Yang LF; Zhu J; Li GC; Zhang Z
    Mol Clin Oncol; 2017 Nov; 7(5):864-868. PubMed ID: 29181181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Treatment Adherence With Oncologic Outcomes for Patients With Rectal Cancer: A Post Hoc Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Diefenhardt M; Ludmir EB; Hofheinz RD; Ghadimi M; Minsky BD; Rödel C; Fokas E
    JAMA Oncol; 2020 Sep; 6(9):1416-1421. PubMed ID: 32644104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0.
    You KY; Huang R; Ding PR; Qiu B; Zhou GQ; Chang H; Xiao WW; Zeng ZF; Pan ZZ; Gao YH
    Int J Colorectal Dis; 2014 Apr; 29(4):529-38. PubMed ID: 24474499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
    Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
    BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
    Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
    Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
    Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
    ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.